HomeOpen Access News

Open Access News

The local government structures shake-up: Reorganisation, impact, and technology needs

Mark Gannon, Director of Client Solution at Netcall, discusses the UK Government’s creation of unitary authorities as part of the abolition of the two-tier local government structures in England and the role of technology in this significant reorganisation.

Norway’s healthcare sector: Prioritising digital solutions in 2021

Open Access Government discuss how the Norwegian Minister for Health and Care Services, Bent Høie has navigated his ministries response to the COVID-19 crisis, and his priorities for 2021.

Over 50% of healthcare workers report one symptom of PTSD

The US is facing a fourth wave of COVID-19, as emergency healthcare workers across the country continue to face the virus and experience levels of burnout that can lead to PTSD.

Mobile app acceleration during the pandemic

Mike Rhodes, CEO of ConsultMyApp, discusses what businesses must do to leverage their mobile apps/digital brand and survive in a post-covid era.

Brexit and COVID-19 will combine to cause an outsourcing boom

Richard Leslie, CEO, The Sourcing Hub, discusses why the COVID-19 pandemic and Brexit could create a boom in outsourcing technology development.

Center for Disease Control says surfaces “low-risk” for COVID transmission

New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.

How is the UK cleaning up its energy?

Open Access Government discuss UK Energy Policy and the priorities that the Rt Hon Kwasi Kwarteng MP has set out for 2021 in his new role as Secretary of State for Business, Energy and Industrial Strategy.

A year with COVID-19: What has healthcare learnt?

Chris Norton, Managing Director, UK & Ireland, InterSystems, discusses the NHS’ current challenges, integrated care efforts, and the ways data and technology can be harnessed to inform care today, and in a post-COVID world.

Defeating late blight disease of potato in sub-Saharan Africa

Three academic experts, including Richard E. Goodman from the Food Allergy Research and Resource Program, shed light on defeating late blight disease of potato in sub-Saharan Africa, starting with a brief introduction to the crop in question.

1 in 10 suffer long-term effects 8 months after mild COVID-19 infection

According to a new study, by researchers at Danderyd Hospital and Karolinska Institutet in Sweden, 1 in 10 people still experience symptoms of COVID-19 8 months after infection.

Cities: Climate change, transport and beyond COVID-19

Jonathan Miles, Editor of Open Access Government, charts the importance of climate change adaptation, the impact of lockdown, transport and the environment in Europe, as highlighted by Eurocities.

Over 700,000 AstraZeneca doses sent from UK to Australia

Today (8 April) it was revealed that over 700,000 AstraZeneca doses manufactured in the UK are being sent to Australia - with a confirmed 300,000 vaccines in Sydney at the end of February.

Advancing science and serving society in the U.S.

Open Access Government explores the work of the American Association for the Advancement of Science (AAAS), and how the organisation continues to ensure that all of society benefit from scientific innovation.

Smart and sustainable mobility for the future

Open Access Government explores Europe’s current smart mobility priorities, learning why Intelligent Transport Solutions (ITS) are key to advancing the transport sector in a sustainable and innovative way.

REACT study: Primary school children have highest COVID infection level

New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.

Blended learning can address one of the UK’s most profound educational issues

Dr Paul Armstrong, The Manchester Institute for Education, University of Manchester, looks at the long-term outlook for the UK education system as we transition out of lockdown, specifically around addressing inequalities that have been exposed during the pandemic.

Healthy under-30s should take alternative vaccine to AstraZeneca

The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders